Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2020

2.1 / 5 stars · 17/40 Roast Me

Add as a preferred source on Google

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2020-12-30: Form 6-K; Period of report 2020-12-30; Description DIRECTOR/PDMR SHAREHOLDING; Document a1625k.htm.
  • 2020-12-23: Form 6-K; Period of report 2020-12-23; Description DIRECTOR/PDMR SHAREHOLDING; Document a7306j.htm.
  • 2020-12-21: Form 6-K; Period of report 2020-12-21; Description VIIV FIRST LONG-ACTING HIV REGIMEN APPROVED IN EU; Document a2551j.htm.
  • 2020-12-11: Form 6-K; Period of report 2020-12-11; Description SANOFI/ GSK UPDATE ON COVID VACCINE CANDIDATE; Document a3066i.htm.
FiledFormPeriod of reportDescriptionDocument
2020-12-306-K2020-12-30DIRECTOR/PDMR SHAREHOLDINGa1625k.htm
2020-12-236-K2020-12-23DIRECTOR/PDMR SHAREHOLDINGa7306j.htm
2020-12-216-K2020-12-21VIIV FIRST LONG-ACTING HIV REGIMEN APPROVED IN EUa2551j.htm
2020-12-116-K2020-12-11SANOFI/ GSK UPDATE ON COVID VACCINE CANDIDATEa3066i.htm
2020-12-106-K2020-12-10DIRECTOR/PDMR SHAREHOLDINGa2996i.htm
2020-12-106-K2020-12-10BLOCK LISTING APPLICATIONa2457i.htm
2020-12-096-K2020-12-09DIRECTOR/PDMR SHAREHOLDINGa1204i.htm
2020-12-036-K2020-12-03DIRECTOR/PDMR SHAREHOLDINGa5232h.htm
2020-12-016-K2020-12-01TOTAL VOTING RIGHTSa1523h.htm
2020-11-276-K2020-11-27GSK PUBLISHES PROVISIONAL 2021 DIVIDEND DATESa8079g.htm
2020-11-276-K2020-11-27EMTN SUPPLEMENTARY PROSPECTUSa6531g.htm
2020-11-256-K2020-11-25DIRECTOR/PDMR SHAREHOLDINGa4785g.htm
2020-11-236-K2020-11-23BLOCK LISTING INTERIM REVIEWa1550g.htm
2020-11-196-K2020-11-19HOLDING(S) IN COMPANYa9398f.htm
2020-11-176-K2020-11-17DIRECTOR/PDMR SHAREHOLDINGa6442f.htm
2020-11-126-K2020-11-12MEDICAGO GSK PHASE 2/3 STUDY STARTa1550f.htm
2020-11-126-K2020-11-12DIRECTOR/PDMR SHAREHOLDINGa0274f.htm
2020-11-126-K2020-11-12DIRECTOR/PDMR SHAREHOLDINGa9891e.htm
2020-11-096-K2020-11-09VIIV'S CABOTEGRAVIR SUPERIOR FOR HIV PREVENTIONa6397e.htm
2020-11-046-K2020-11-04DIRECTOR/PDMR SHAREHOLDINGa3030e.htm
2020-11-046-K2020-11-04DIRECTOR/PDMR SHAREHOLDINGa2950e.htm
2020-11-036-K2020-11-03DIRECTOR/PDMR SHAREHOLDINGa1457e.htm
2020-11-036-K2020-11-03GSK SETS NEW ENVIRONMENTAL GOALSa0743e.htm
2020-11-026-K2020-11-02DIRECTOR/PDMR SHAREHOLDINGa0091e.htm
2020-11-026-K2020-11-02TOTAL VOTING RIGHTSa9965d.htm
2020-10-306-K2020-10-30HOLDING(S) IN COMPANYa8338d.htm
2020-10-306-K2020-10-30DIRECTOR/PDMR SHAREHOLDINGa7994d.htm
2020-10-286-K2020-10-28DIRECTOR/PDMR SHAREHOLDINGa5384d.htm
2020-10-286-K2020-10-283RD QUARTER RESULTSa4952d.htm
2020-10-286-K2020-10-28SANOFI AND GSK SUPPORT COVAX - 200M VACCINE DOSESa4499d.htm
2020-10-226-K2020-10-22HOLDING(S) IN COMPANYa9499c.htm
2020-10-166-K2020-10-16POSITIVE CHMP OPINION VIIV LONG-ACTING HIV REGIMENa3642c.htm
2020-10-146-K2020-10-14DIRECTOR/PDMR SHAREHOLDINGa1069c.htm
2020-10-146-K2020-10-14DIRECTOR/PDMR SHAREHOLDINGa1070c.htm
2020-10-136-K2020-10-13DIRECTOR/PDMR SHAREHOLDINGa9609b.htm
2020-10-136-K2020-10-13DIRECTOR/PDMR SHAREHOLDINGa9569b.htm
2020-10-136-K2020-10-13DIRECTOR/PDMR SHAREHOLDINGa9581b.htm
2020-10-136-K2020-10-13DIRECTOR/PDMR SHAREHOLDINGa9563b.htm
2020-10-136-K2020-10-13DIRECTOR/PDMR SHAREHOLDINGa9557b.htm
2020-10-016-K2020-10-01TOTAL VOTING RIGHTSa8678a.htm
2020-10-016-K2020-10-016-Kd93705d6k.htm
2020-09-286-K2020-09-286-Kd20089d6k.htm
2020-09-226-K2020-09-22SANOFI/GSK AGREE UP TO 72M CANADA COVID DOSESa7865z.htm
2020-09-116-K2020-09-11DIRECTOR/PDMR SHAREHOLDINGa7983y.htm
2020-09-106-K2020-09-10DIRECTOR/PDMR SHAREHOLDINGa6219y.htm
2020-09-096-K2020-09-09DIRECTOR/PDMR SHAREHOLDINGa5215y.htm
2020-09-096-K2020-09-09DIRECTOR/PDMR SHAREHOLDINGa5039y.htm
2020-09-036-K2020-09-03SANOFI/GSK: PHASE 1/2 TRIAL OF COVID-19 VACCINEa9210x.htm
2020-09-016-K2020-09-01TOTAL VOTING RIGHTSa7169x.htm
2020-08-136-K2020-08-13DIRECTOR/PDMR SHAREHOLDINGa0656w.htm
2020-08-066-K2020-08-06US FDA APPROVES GSKS BLENREP FOR MULTIPLE MYELOMAa3020v.htm
2020-08-036-K2020-08-03TOTAL VOTING RIGHTSa9476u.htm
2020-08-036-K2020-08-03SANOFI/GSK TO SUPPLY EU WITH 300M COVID 19 DOSESa8518u.htm
2020-07-316-K2020-07-31SANOFI & GSK PICKED FOR OP. WARP SPEED BY US GOV.a7911u.htm
2020-07-296-K2020-07-292ND QUARTER RESULTSa4934u.htm
2020-07-296-K2020-07-29DIRECTOR/PDMR SHAREHOLDINGa5090u.htm
2020-07-296-K2020-07-29SANOFI AND GSK AGREE UK DOSES OF COVID 19 VACCINEa4014u.htm
2020-07-286-K2020-07-28DIRECTOR/PDMR SHAREHOLDINGa3726u.htm
2020-07-246-K2020-07-24GSK RECEIVES POSITIVE CHMP OPINION FOR BELAMAFa0569u.htm
2020-07-206-K2020-07-20GSK AND CUREVAC ENTER COLLABORATIONa4170t.htm
2020-07-156-K2020-07-15DIRECTOR/PDMR SHAREHOLDINGa0731t.htm
2020-07-156-K2020-07-15FDA PANEL VOTES IN FAVOR OF BELANTAMAB MAFODOTINa0118t.htm
2020-07-146-K2020-07-14DIRECTOR/PDMR SHAREHOLDINGa9738s.htm
2020-07-136-K2020-07-13DIRECTOR/PDMR SHAREHOLDINGa8746s.htm
2020-07-106-K2020-07-10DIRECTOR/PDMR SHAREHOLDINGa7237s.htm
2020-07-106-K2020-07-10DIRECTOR/PDMR SHAREHOLDINGa7183s.htm
2020-07-106-K2020-07-10DIRECTOR/PDMR SHAREHOLDINGa7175s.htm
2020-07-016-K2020-07-01TOTAL VOTING RIGHTSa7369r.htm
2020-06-296-K2020-06-29GSK'S DAPRODUSTAT GAINS FIRST REGULATORY APPROVALa3500r.htm
2020-06-196-K2020-06-19FDA ADVISORY COMMITTEE REVIEW BELANTAMAB MAFODOTINa5493q.htm
2020-06-186-K2020-06-18DIRECTOR/PDMR SHAREHOLDINGa4042q.htm
2020-06-186-K2020-06-186-Kform6k.htm
2020-06-176-K2020-06-176-Kform6k.htm
2020-06-166-K2020-06-16DIRECTOR/PDMR SHAREHOLDINGa1353q.htm
2020-06-116-K2020-06-11DIRECTOR/PDMR SHAREHOLDINGa7207p.htm
2020-06-096-K2020-06-09DIRECTOR/PDMR SHAREHOLDINGa4358p.htm
2020-06-016-K2020-06-01TOTAL VOTING RIGHTSa5579o.htm
2020-05-266-K2020-05-26BLOCK LISTING INTERIM REVIEWa9478n.htm
2020-05-196-K2020-05-19HOLDING(S) IN COMPANYa4015n.htm
2020-05-186-K2020-05-18VIIV PREP JAB SHOWS HIGH EFFICACY OVER DAILY PILLa1804n.htm
2020-05-136-K2020-05-13DIRECTOR/PDMR SHAREHOLDINGa8278m.htm
2020-05-126-K2020-05-126-Kform6k.htm
2020-05-116-K2020-05-11DIRECTOR/PDMR SHAREHOLDINGa5534m.htm
2020-05-076-K2020-05-07DIRECTOR/PDMR SHAREHOLDINGa3256m.htm
2020-05-066-K2020-05-06RESULT OF AGMa1855m.htm
2020-05-046-K2020-05-04DIRECTOR/PDMR SHAREHOLDINGa8810l.htm
2020-05-046-K2020-05-04PUBLICATION OF A PROSPECTUSa8799l.htm
2020-05-046-K2020-05-04RIGHTS ATTACHED TO ORDINARY SHARESa8656l.htm
2020-05-016-K2020-05-01TOTAL VOTING RIGHTSa7132l.htm
2020-04-306-K2020-04-30GSK'S ZEJULA APPROVED IN FIRST-LINE OVARIAN CANCERa4003l.htm
2020-04-296-K2020-04-291ST QUARTER RESULTSa3184l.htm
2020-04-296-K2020-04-29ARRANGEMENTS FOR SHAREHOLDER WEBCASTa3192l.htm
2020-04-166-K2020-04-16DIRECTOR/PDMR SHAREHOLDINGa9333j.htm
2020-04-166-K2020-04-16DIRECTOR/PDMR SHAREHOLDINGa9259j.htm
2020-04-166-K2020-04-16DIRECTOR/PDMR SHAREHOLDINGa9214j.htm
2020-04-146-K2020-04-14DIRECTOR/PDMR SHAREHOLDINGa6317j.htm
2020-04-146-K2020-04-14DIRECTOR/PDMR SHAREHOLDINGa6321j.htm
2020-04-146-K2020-04-14DIRECTOR/PDMR SHAREHOLDINGa6208j.htm
2020-04-146-K2020-04-14SANOFI AND GSK COLLABORATION TO FIGHT COVID-19a5854j.htm
2020-04-096-K2020-04-09AGM - CHANGE OF ARRANGEMENTSa3879j.htm
Advertisement